Gunduztepe, Y. Et Al. 2020. The evaluation of thiol-disulfite balance, ischemia albumin modification and seruloplazmine as a new oxidative stress in mild cognitive impairment and early stage alzheimer's disease patients. JOURNAL OF CLINICAL NEUROSCIENCE , vol.75 , 188-194.

Gunduztepe, Y., BUKAN, N., Zorlu, E., Karaman, Y., Topkan, T. A., Gurbuz, N., ... NEŞELİOĞLU, S.(2020). The evaluation of thiol-disulfite balance, ischemia albumin modification and seruloplazmine as a new oxidative stress in mild cognitive impairment and early stage alzheimer's disease patients. JOURNAL OF CLINICAL NEUROSCIENCE , vol.75, 188-194.

Gunduztepe, Yasemin Et Al. "The evaluation of thiol-disulfite balance, ischemia albumin modification and seruloplazmine as a new oxidative stress in mild cognitive impairment and early stage alzheimer's disease patients," JOURNAL OF CLINICAL NEUROSCIENCE , vol.75, 188-194, 2020

Gunduztepe, Yasemin Et Al. "The evaluation of thiol-disulfite balance, ischemia albumin modification and seruloplazmine as a new oxidative stress in mild cognitive impairment and early stage alzheimer's disease patients." JOURNAL OF CLINICAL NEUROSCIENCE , vol.75, pp.188-194, 2020

Gunduztepe, Y. Et Al. (2020) . "The evaluation of thiol-disulfite balance, ischemia albumin modification and seruloplazmine as a new oxidative stress in mild cognitive impairment and early stage alzheimer's disease patients." JOURNAL OF CLINICAL NEUROSCIENCE , vol.75, pp.188-194.

@article{article, author={Yasemin Gunduztepe Et Al. }, title={The evaluation of thiol-disulfite balance, ischemia albumin modification and seruloplazmine as a new oxidative stress in mild cognitive impairment and early stage alzheimer's disease patients}, journal={JOURNAL OF CLINICAL NEUROSCIENCE}, year=2020, pages={188-194} }